Cord blood disorders is speculative, some research has been done in other areas. Any such potential beyond blood and immunological uses is limited by the fact that cord cells are hematopoietic stem cells (which can differentiate only into blood cells), and not pluripotent stem cells (such as embryonic stem cells, which can differentiate into any type of tissue). Cord blood has been studied as a treatment for diabetes. However, apart from blood disorders, the use of cord blood for other diseases is not in routine clinical use and remains a major challenge for the stem cell community. Along with cord blood, Wharton's
ICD-10 Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism ICD-10 Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism ICD-10 is an international statistical classification used in health care and related industries. Produced by the World Health Organization, it is used in several countries around the world. Some have gone on to develop their own national enhancements, building off the international version of the classification. Chapter III of ICD-10 deals with diseases of the blood, for example anaemia, blood-forming organs, and certain disorders involving the immune mechanism. Of note; blood cancers, such as leukaemia, are covered in . Also blood infections is